Clairity


Clairity provides an AI-powered precision health platform focused on predicting future disease risk from routine medical imaging. Its product, Clairity Breast, uses only a standard screening mammogram to generate a five-year risk estimate of developing breast cancer. The system analyzes subtle patterns in breast tissue that may not be visible to human readers, generating a risk score intended to support clinical decision making rather than diagnose disease. Clairity is also working to extend its predictive imaging framework into other areas of health beyond breast cancer.
HQ: Austin, Texas, United States
Country: USA
Estimated Employees:
11 .. 50
Estimated Revenues
$M 0.00
Raised Funding:
$M 49.67
AI Categories:


